Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Mandonnet, E; Wager, M; Almairac, F; Baron, MH; Blonski, M; Freyschlag, CF; Barone, F; Fontaine, D; Pallud, J; Hegi, M; Viegas, C; Zetterling, M; Spena, G; Goodden, J; Rutten, GJ; Taillandier, L; Foroglu, N; Darlix, A; Skrap, M; Martino, J; von Campe, G; Madadaki, C; Gayat, E; de Witt Hamer, P; Gil Robles, S; Sarubbo, S; Santarius, T; Bello, L; Forster, MT; Duffau, H.
Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step?
Neurooncol Pract. 2017; 4(4):241-247
Doi: 10.1093/nop/npw031
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- von Campe Gord
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Diffuse low-grade glioma form a rare entity affecting young people. Despite advances in surgery, chemotherapy, and radiation therapy, diffuse low-grade glioma are still incurable. According to current guidelines, maximum safe resection, when feasible, is the first line of treatment. Apart from surgery, all other treatment modalities (temozolomide, procarbazine-CCNU-vincristine regimen, and radiation therapy) are handled very differently among different teams, and this in spite of recent results of several phase 3 studies. Based on a European survey, this paper aimed to get a picture of this heterogeneity in diffuse low-grade glioma management, to identify clinically relevant questions raised by this heterogeneity of practice, and to propose new methodological frameworks to address these questions.
- Find related publications in this database (Keywords)
- diffuse low-grade glioma
- evidence-based medicine
- GLIOCOM
- surgery
- survey